The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.
about
Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implicationsFocus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's DiseaseCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationNeutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD MouseGene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.Regulation of Chlamydomonas flagella and ependymal cell motile cilia by ceramide-mediated translocation of GSK3Extracellular vesicles of the blood-brain barrier.Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic MicePlasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease.The role of exosomes in the pathogenesis of Alzheimer' disease.Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology.Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases.Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease.Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders.Exosome isolation from distinct biofluids using precipitation and column-based approaches.
P2860
Q26740418-16F0E7A9-4A89-44A7-BEAD-EE7A4B1D0EEAQ26767264-F384ABD5-736F-4B83-9EB2-0E06AE4FAF9FQ28087030-D83FF15B-E53F-43A6-836F-A9A7AFE1AB84Q30363059-41D46755-0F89-44AD-906C-3E2EFC75A2FFQ36039529-23BF30C5-A7D2-4D51-9A16-6173BBA61FCDQ36337044-EBCEB5FD-02FA-4582-B11A-E2667FCC4D53Q36812442-E732DC3E-FC20-42FA-A58F-3C259777A1ECQ37610732-1C925DC1-2092-4DB0-ABFB-8915515D9074Q37617386-A7B12724-EA0F-4F73-A1D0-6FCDE41699B1Q37621060-A49E93D2-97D9-408B-99C3-FA2E9B6D0743Q40389352-E65B4167-9F71-4B21-B40B-576EC5004AC1Q41605967-77916564-30BF-4287-95B2-D0277B2AB4D1Q46288375-FBBE2500-5E0F-435A-85A9-064EE41B9215Q47587274-AED1A7C5-5097-496D-857E-51537E43C28FQ55122433-B66837B4-FF32-4F73-B402-374565C0923EQ55314606-94890CCB-F5F1-4DD1-8E3E-DAE052FFE5C1
P2860
The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@ast
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@en
type
label
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@ast
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@en
prefLabel
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@ast
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@en
P2093
P2860
P356
P1476
The 5XFAD Mouse Model of Alzhe ...... ers and Amyloid Plaque Burden.
@en
P2093
Erhard Bieberich
Guanghu Wang
Ji Na Kong
Michael B Dinkins
Somsankar Dasgupta
P2860
P356
10.3233/JAD-150088
P577
2015-02-26T00:00:00Z